Divi's Laboratories vs Dr. Reddy’s: share price, P/E, ROE and financials compared
Divi's Laboratories
Dr. Reddy's Laboratories
Divi's Laboratories and Dr. Reddy’s at a glance
Divi's Laboratories and Dr. Reddy’s are both listed in Healthcare. Divi's Laboratories is the larger by market cap, at ₹2.7L Cr against ₹1.1L Cr for Dr. Reddy’s (2.4 times as large). On valuation, Dr. Reddy’s has the lower P/E (40.9× against 93.6×) and the lower price-to-book (2.96× against 16.35×). On returns and margins, Divi's Laboratories has the higher ROCE (19.0% against 14.2%), the higher ROE (16.2% against 7.3%) and the higher operating margin (34.9% against 15.9%). Over three years, Divi's Laboratories has faster 3-year profit growth (+12.1% against −1.7% a year). Divi's Laboratories carries less debt for its equity, with a debt-to-equity of 0.00× against 0.19×.
Key metrics, side by side
| Metric | Divi's LaboratoriesDIVISLAB | Dr. Reddy’sDRREDDY |
|---|---|---|
| Price (₹) | 10,320.50 | 1,373.00 |
| Market cap (₹ Cr) | 2,73,977 | 1,14,462 |
| P/E | 93.6× | 40.9× (the lower figure, shaded) |
| P/B | 16.35× | 2.96× (the lower figure, shaded) |
| Dividend yield, trailing | 0.29% | 0.58% (the higher figure, shaded) |
| ROE | 16.2% (the higher figure, shaded) | 7.3% |
| ROCE | 19.0% (the higher figure, shaded) | 14.2% |
| Operating margin (OPM) | 34.9% (the higher figure, shaded) | 15.9% |
| Net margin (NPM) | 26.0% (the higher figure, shaded) | 8.5% |
| Sales CAGR 3Y | +11.0% | +11.0% |
| Profit CAGR 3Y | +12.1% (the higher figure, shaded) | −1.7% |
| Debt to equity | 0.00× (the lower figure, shaded) | 0.19× |
| Interest cover | 148.3× (the higher figure, shaded) | 15.7× |
| Net profit TTM (₹ Cr) | – | 2,799 |
| 1Y return | +49.0% (the higher figure, shaded) | +13.8% |
| Promoter holding | – | – |
Divi's Laboratories vs Dr. Reddy’s: common questions
Which is bigger, Divi's Laboratories or Dr. Reddy’s?
By market cap, Divi's Laboratories is bigger at ₹2.7L Cr, against ₹1.1L Cr for Dr. Reddy’s (prices as of 6 Nov 2026).
Which has a lower P/E ratio, Divi's Laboratories or Dr. Reddy’s?
Divi's Laboratories trades at a P/E of 93.6× and Dr. Reddy’s at 40.9×. Dr. Reddy’s has the lower P/E. P/E is the share price divided by earnings per share; it varies a lot between industries and with growth, so it says little on its own.
Which has a higher ROE, Divi's Laboratories or Dr. Reddy’s?
Divi's Laboratories reports a return on equity of 16.2% and Dr. Reddy’s 7.3%. Divi's Laboratories has the higher ROE. ROE is net profit as a share of shareholders’ equity.
Which is growing faster, Divi's Laboratories or Dr. Reddy’s?
Over the last three years: Sales grew +11.0% a year at Divi's Laboratories and +11.0% at Dr. Reddy’s; profit grew +12.1% a year at Divi's Laboratories and −1.7% at Dr. Reddy’s, so Divi's Laboratories grew profit faster. Past growth doesn’t predict future growth.